NCT00111280View on ClinicalTrials.gov

TMC125-C211: Trial of TMC125 in HIV-1 Infected Subjects Who Were in a Sponsor Selected TMC125 Trial

PHASE2CompletedINTERVENTIONAL

Enrollment

48

Participants

Timeline

Start Date

September 30, 2004

Study Completion Date

March 31, 2007

Conditions

HIV Infection

Interventions

DRUG

TMC125

All Listed Sponsors

lead

Tibotec Pharmaceuticals, Ireland

INDUSTRY

NCT00111280 - TMC125-C211: Trial of TMC125 in HIV-1 Infected Subjects Who Were in a Sponsor Selected TMC125 Trial | Biotech Hunter | Biotech Hunter